Advertisement
Screener

BOSTON SCIENTIFIC CORPORATION (BSX) SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense

3.0 / 5 stars · 73/120 Roast Me

BOSTON SCIENTIFIC CORPORATION SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense

BOSTON SCIENTIFIC CORPORATION (BSX) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense of $28.00 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-03.

Financial Statements › Notes › Valuation and Qualifying Accounts

us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense · last filed 2025-11-03

  • BOSTON SCIENTIFIC CORPORATION sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for the quarter ending 2025-09-30 was $28.00M, a 180.00% increase year-over-year.
  • BOSTON SCIENTIFIC CORPORATION sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for the quarter ending 2025-06-30 was $4.00M, a 66.67% decline year-over-year.
  • BOSTON SCIENTIFIC CORPORATION sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for the quarter ending 2025-03-31 was $17.00M, a 88.89% increase year-over-year.
  • BOSTON SCIENTIFIC CORPORATION sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for the quarter ending 2024-09-30 was $10.00M, a 0.00% change year-over-year.
  • BOSTON SCIENTIFIC CORPORATION sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2019 was $23.00M, a 21.05% increase from fiscal 2018.
  • BOSTON SCIENTIFIC CORPORATION sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2018 was $19.00M, a 35.71% increase from fiscal 2017.
  • BOSTON SCIENTIFIC CORPORATION sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2017 was $14.00M, a 55.56% increase from fiscal 2016.
  • BOSTON SCIENTIFIC CORPORATION sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2016 was $9.00M, a 40.00% decline from fiscal 2015.
Period endSEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 3 monthSEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 6 monthSEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 9 monthSEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month
2025-09-30$28.00M
10-Q · filed 2025-11-03
$32.00M
derived: sum of 2 quarters · filed 2025-11-03
$49.00M
10-Q · filed 2025-11-03
2025-06-30$4.00M
10-Q · filed 2025-08-01
$21.00M
10-Q · filed 2025-08-01
2025-03-31$17.00M
10-Q · filed 2025-05-01
2024-09-30$10.00M
10-Q · filed 2025-11-03
$22.00M
derived: sum of 2 quarters · filed 2025-11-03
$30.00M
10-Q · filed 2025-11-03
2024-06-30$12.00M
10-Q · filed 2025-08-01
$21.00M
10-Q · filed 2025-08-01
2024-03-31$9.00M
10-Q · filed 2025-05-01
2023-09-30$10.00M
10-Q · filed 2024-11-01
$29.00M
derived: sum of 2 quarters · filed 2024-11-01
$44.00M
10-Q · filed 2024-11-01
2023-06-30$19.00M
10-Q · filed 2024-08-01
$35.00M
10-Q · filed 2024-08-01
2023-03-31$16.00M
10-Q · filed 2024-05-01
2022-09-30$7.00M
10-Q · filed 2023-11-01
$16.00M
derived: sum of 2 quarters · filed 2023-11-01
$26.00M
10-Q · filed 2023-11-01
2022-06-30$9.00M
10-Q · filed 2023-08-03
$20.00M
10-Q · filed 2023-08-03
2022-03-31$11.00M
10-Q · filed 2023-05-04
2021-09-30$9.00M
10-Q · filed 2022-11-03
$18.00M
derived: sum of 2 quarters · filed 2022-11-03
$20.00M
10-Q · filed 2022-11-03
2021-06-30$9.00M
10-Q · filed 2022-08-04
$11.00M
10-Q · filed 2022-08-04
2021-03-31$2.00M
10-Q · filed 2022-05-05
2020-09-30$16.00M
10-Q · filed 2021-11-04
$30.00M
derived: sum of 2 quarters · filed 2021-11-04
$39.00M
10-Q · filed 2021-11-04
$43.00M
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30$14.00M
10-Q · filed 2021-08-06
$22.00M
10-Q · filed 2021-08-06
$27.00M
derived: sum of 3 quarters · filed 2021-08-06
$35.00M
derived: sum of 4 quarters · filed 2021-08-06
2020-03-31$9.00M
10-Q · filed 2021-05-06
$13.00M
derived: sum of 2 quarters · filed 2021-05-06
$21.00M
derived: sum of 3 quarters · filed 2021-05-06
$25.00M
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$12.00M
derived: sum of 2 quarters · filed 2020-11-05
$16.00M
derived: sum of 3 quarters · filed 2020-11-05
$23.00M
10-K · filed 2020-02-25
2019-09-30$8.00M
10-Q · filed 2020-11-05
$12.00M
derived: sum of 2 quarters · filed 2020-11-05
$19.00M
10-Q · filed 2020-11-05
$23.00M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$4.00M
10-Q · filed 2020-08-05
$11.00M
10-Q · filed 2020-08-05
$15.00M
derived: sum of 3 quarters · filed 2020-08-05
$21.00M
derived: sum of 4 quarters · filed 2020-08-05
2019-03-31$7.00M
10-Q · filed 2020-05-06
$11.00M
derived: sum of 2 quarters · filed 2020-05-06
$17.00M
derived: sum of 3 quarters · filed 2020-05-06
$21.00M
derived: sum of 4 quarters · filed 2020-05-06
2018-12-31$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$10.00M
derived: sum of 2 quarters · filed 2020-02-25
$14.00M
derived: sum of 3 quarters · filed 2020-02-25
$19.00M
10-K · filed 2020-02-25
2018-09-30$6.00M
10-Q · filed 2019-11-05
$10.00M
derived: sum of 2 quarters · filed 2019-11-05
$15.00M
10-Q · filed 2019-11-05
$14.00M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$4.00M
10-Q · filed 2019-07-30
$8.00M
10-Q · filed 2019-07-30
$8.00M
derived: sum of 3 quarters · filed 2020-02-25
$17.00M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$4.00M
10-Q · filed 2019-04-29
$4.00M
derived: sum of 2 quarters · filed 2020-02-25
$13.00M
derived: sum of 3 quarters · filed 2020-02-25
$15.00M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$9.00M
derived: sum of 2 quarters · filed 2020-02-25
$11.00M
derived: sum of 3 quarters · filed 2020-02-25
$14.00M
10-K · filed 2020-02-25
2017-09-30$9.00M
10-Q · filed 2018-10-29
$11.00M
derived: sum of 2 quarters · filed 2018-10-29
$14.00M
10-Q · filed 2018-10-29
$18.00M
derived: sum of 4 quarters · filed 2019-02-19
2017-06-30$2.00M
10-Q · filed 2018-07-31
$5.00M
10-Q · filed 2018-07-31
$9.00M
derived: sum of 3 quarters · filed 2019-02-19
$8.00M
derived: sum of 4 quarters · filed 2019-02-19
2017-03-31$3.00M
10-Q · filed 2018-05-01
$7.00M
derived: sum of 2 quarters · filed 2019-02-19
$6.00M
derived: sum of 3 quarters · filed 2019-02-19
$9.00M
derived: sum of 4 quarters · filed 2019-02-19
2016-12-31$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19
$3.00M
derived: sum of 2 quarters · filed 2019-02-19
$6.00M
derived: sum of 3 quarters · filed 2019-02-19
$9.00M
10-K · filed 2019-02-19
2016-09-30-$1.00M
10-Q · filed 2017-11-02
$2.00M
derived: sum of 2 quarters · filed 2017-11-02
$5.00M
10-Q · filed 2017-11-02
$10.00M
derived: sum of 4 quarters · filed 2018-02-20
2016-06-30$3.00M
10-Q · filed 2017-08-03
$7.00M
10-Q · filed 2017-08-03
$11.00M
derived: sum of 3 quarters · filed 2018-02-20
$14.00M
derived: sum of 4 quarters · filed 2018-02-20
2016-03-31$4.00M
10-Q · filed 2017-05-03
$8.00M
derived: sum of 2 quarters · filed 2018-02-20
$11.00M
derived: sum of 3 quarters · filed 2018-02-20
$17.00M
derived: sum of 4 quarters · filed 2018-02-20
2015-12-31$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20
$7.00M
derived: sum of 2 quarters · filed 2018-02-20
$13.00M
derived: sum of 3 quarters · filed 2018-02-20
$15.00M
10-K · filed 2018-02-20
2015-09-30$3.00M
10-Q · filed 2016-11-03
$9.00M
derived: sum of 2 quarters · filed 2016-11-03
$11.00M
10-Q · filed 2016-11-03
$17.00M
derived: sum of 4 quarters · filed 2017-02-23
2015-06-30$6.00M
10-Q · filed 2016-08-03
$8.00M
10-Q · filed 2016-08-03
$14.00M
derived: sum of 3 quarters · filed 2017-02-23
$14.00M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-31$2.00M
10-Q · filed 2016-05-04
$8.00M
derived: sum of 2 quarters · filed 2017-02-23
$8.00M
derived: sum of 3 quarters · filed 2017-02-23
$14.00M
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
$6.00M
derived: sum of 2 quarters · filed 2017-02-23
$12.00M
derived: sum of 3 quarters · filed 2017-02-23
$10.00M
10-K · filed 2017-02-23
2014-09-30$0.00
10-Q · filed 2015-11-04
$6.00M
derived: sum of 2 quarters · filed 2015-11-04
$4.00M
10-Q · filed 2015-11-04
$2.00M
derived: sum of 4 quarters · filed 2016-02-24
2014-06-30$6.00M
10-Q · filed 2015-08-06
$4.00M
10-Q · filed 2015-08-06
$2.00M
derived: sum of 3 quarters · filed 2016-02-24
$4.00M
derived: sum of 4 quarters · filed 2016-02-24
2014-03-31-$2.00M
10-Q · filed 2015-05-06
-$4.00M
derived: sum of 2 quarters · filed 2016-02-24
-$2.00M
derived: sum of 3 quarters · filed 2016-02-24
$1.00M
derived: sum of 4 quarters · filed 2016-02-24
2013-12-31-$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24
$0.00
derived: sum of 2 quarters · filed 2016-02-24
$3.00M
derived: sum of 3 quarters · filed 2016-02-24
$5.00M
10-K · filed 2016-02-24
2013-09-30$2.00M
10-Q · filed 2014-11-05
$5.00M
derived: sum of 2 quarters · filed 2014-11-05
$7.00M
10-Q · filed 2014-11-05
$15.00M
derived: sum of 4 quarters · filed 2015-02-25
2013-06-30$3.00M
10-Q · filed 2014-08-06
$6.00M
10-Q · filed 2014-08-06
$13.00M
derived: sum of 3 quarters · filed 2015-02-25
$14.00M
derived: sum of 4 quarters · filed 2015-02-25
2013-03-31$3.00M
10-Q · filed 2014-05-08
$10.00M
derived: sum of 2 quarters · filed 2015-02-25
$11.00M
derived: sum of 3 quarters · filed 2015-02-25
$8.00M
derived: sum of 4 quarters · filed 2015-02-25
2012-12-31$7.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25
$8.00M
derived: sum of 2 quarters · filed 2015-02-25
$5.00M
derived: sum of 3 quarters · filed 2015-02-25
$14.00M
10-K · filed 2015-02-25
2012-09-30$1.00M
10-Q · filed 2013-11-05
-$2.00M
derived: sum of 2 quarters · filed 2013-11-05
$7.00M
10-Q · filed 2013-11-05
$17.00M
derived: sum of 4 quarters · filed 2014-02-26
2012-06-30-$3.00M
10-Q · filed 2013-08-07
$6.00M
10-Q · filed 2013-08-07
$16.00M
derived: sum of 3 quarters · filed 2014-02-26
$28.00M
derived: sum of 4 quarters · filed 2014-02-26
2012-03-31$9.00M
10-Q · filed 2013-05-07
$19.00M
derived: sum of 2 quarters · filed 2014-02-26
$31.00M
derived: sum of 3 quarters · filed 2014-02-26
$39.00M
derived: sum of 4 quarters · filed 2014-02-26
2011-12-31$10.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26
$22.00M
derived: sum of 2 quarters · filed 2014-02-26
$30.00M
derived: sum of 3 quarters · filed 2014-02-26
$11.00M
10-K · filed 2014-02-26
2011-09-30$12.00M
10-Q · filed 2012-11-06
$20.00M
derived: sum of 2 quarters · filed 2012-11-06
$1.00M
10-Q · filed 2012-11-06
$11.00M
derived: sum of 4 quarters · filed 2013-05-29
2011-06-30$8.00M
10-Q · filed 2012-08-07
-$11.00M
10-Q · filed 2012-08-07
-$1.00M
derived: sum of 3 quarters · filed 2013-05-29
$5.00M
derived: sum of 4 quarters · filed 2013-05-29
2011-03-31-$19.00M
10-Q · filed 2012-05-03
-$9.00M
derived: sum of 2 quarters · filed 2013-05-29
-$3.00M
derived: sum of 3 quarters · filed 2013-05-29
$5.00M
derived: sum of 4 quarters · filed 2013-05-29
2010-12-31$10.00M
derived: 8-K 12 month − 10-Q 9 month · filed 2013-05-29
$16.00M
derived: sum of 2 quarters · filed 2013-05-29
$24.00M
derived: sum of 3 quarters · filed 2013-05-29
$27.00M
8-K · filed 2013-05-29
2010-09-30$6.00M
10-Q · filed 2011-11-08
$14.00M
derived: sum of 2 quarters · filed 2011-11-08
$17.00M
10-Q · filed 2011-11-08
2010-06-30$8.00M
10-Q · filed 2011-08-05
$11.00M
10-Q · filed 2011-08-05
2009-12-31$27.00M
10-K · filed 2012-02-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
BECTON DICKINSON & CO (BDX)United States$48.834B43.79
3M CO (MMM)United States$86.404B27.87
DEXCOM INC (DXCM)United States$33.004B25.42
WEST PHARMACEUTICAL SERVICES INC (WST)United States$26.288B43.14
STRYKER CORP (SYK)United States$103.511B32.39
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12